Advocacy

FORCE advocates for families facing hereditary breast and ovarian cancer in areas such as access to care, research funding, insurance, and privacy.

Advocacy > Issues > High-Risk Individuals Often Struggle to Get Insurance Coverage of Health Services

| More

Newsflash

11/26/2018
FORCE endorsed HR 6836, the Clinical Treatment Act, which would ensure that states cover routine care costs for Medicaid enrollees who participate in approved clinical trials.

9/26/2018
FORCE joined nearly 100 patient advocacy orgs in expressing concern about allowing Medicare Advantage plans to use step therapy. Read letter...

9/13/2018
We joined in a letter encouraging the House Ways and Means Committee to make the 7.5% medical expense deduction permanent.

9/7/2018
We sent a letter to Senator Collins (R-ME) seeking her leadership on national oral parity legislation

9/5/2018
FORCE signed on to a coalition letter urging the Senate to maintain the allowed medical expense deduction at 7.5% of one's adjusted gross income.

High-Risk Individuals Often Struggle to Get Insurance Coverage of Health Services

Insurance Coverage & Barriers

Overview

The Patient Protection and Affordable Care Act (ACA) guarantees coverage of a number of essential health services and cancer screenings at no cost to the patient.* This has allowed many Americans to access care that they might not otherwise have been able to afford. As many in the hereditary cancer community have learned, however, health insurers are not required to cover cancer screenings beyond those mandated in the ACA, which are focused on the “average risk” population. Members of our high-risk community often struggle to get coverage for earlier, more intensive cancer screenings and risk-reducing surgeries. This is why FORCE has developed sample appeal letters for a variety of screening and preventive services.

Under the ACA, any preventive service receiving a grade “A” or “B” from the U.S. Preventive Services Task Force (USPSTF) must be covered by most group health plans with no out-of-pocket costs to the patient. This includes important screenings for cervical cancer (women ages 21-65), colorectal cancer (adults ages 50-75), and mammograms (women ages 40-74), as well as BRCA genetic counseling and testing for women who are suspected to be at increased risk of breast or ovarian cancer.

With the exception of BRCA testing for women, however, the covered preventive services are for the “average risk” population. Screening recommendations for those at increased risk of cancer go above and beyond those provided under ACA. For example, the National Comprehensive Cancer Network (NCCN) guidelines for women with BRCA mutations recommends that they begin annual breast MRI screenings with contrast between ages 25-29 and annual mammograms with consideration of tomosynthesis should be added at age 30. Those with ATM, PALB2, CDH1, CHEK2 and other mutations should also start mammograms earlier and/or undergo breast screening MRIs. NCCN guidelines for colorectal cancer recommend that colonoscopies should begin at ages 20-25 or 2-5 years prior to the earliest colon cancer in the family for those with Lynch Syndrome.

Because these screenings are not recommended by the USPSTF or required under the ACA, insurers are not required to cover them. They may claim that the services are "not medically necessary" or "experimental." As a result, women who need an annual breast MRI may end up paying thousands of dollars out of pocket every year. Likewise, women under the age of 40 seeking mammograms and those needing colonoscopies before age 50 may have to meet their deductible or incur a significant copay because they don’t yet qualify for these screenings at no cost-sharing under the ACA. Previvors undergoing risk-reducing surgeries, while often covered by insurers, may face significant costs depending on their insurance plan, deductible, etc. Even access to genetic testing can be a challenge for some as testing men is not included in the USPSTF BRCA-related cancer risk assessment guidelines and testing for mutations in genes other than BRCA is not addressed.  

In an ideal world, the USPSTF would address the unique screening and prevention needs of the high-risk cancer community, but it has yet to do so. Alternatively, all health insurers could follow the NCCN guidelines, covering the recommended interventions with limited or no out-of-pocket costs for the patient. Unfortunately, this is not currently the case. We recognize that this presents a challenge for members of our community and continue to actively advocate for affordable coverage of health services for those at increased risk of cancer.

In the meantime, visit our Health Insurance Appeals webpage to learn more and to access downloadable sample appeal letters for a broad range of services and interventions. These letters cite a variety of medical society guidelines, clarifying the appropriate health services for members of the hereditary cancer community and providing evidence of medical necessity.

Securing insurance coverage of a needed screening or surgery does not mean that you will have no out-of-pocket expenses. Depending on your health plan, you can expect to be charged a copay or for the costs to be applied toward your deductible. However, the overall cost to you will be less--often by a significant amount--than the cost would be without insurance coverage. Click on the Advanced Reading tab above for additional information on paying for care and financial assistance programs for those in need.

Need help with an appeal for a service or treatment not listed? Let us know.

* Note: A small number of group health insurance plans, often self-funded, are exempt from the ACA. Additionally, Medicaid and Medicare have their own rules and guidelines for coverage of preventive services.

Search Policy Issues by Keyword

FORCE:Facing Our Risk of Cancer Empowered